These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6661985)

  • 1. Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
    Benvenuti M; Legnaioli M; Melone F; Taddei I; Tarquini B
    Chronobiologia; 1983; 10(4):383-6. PubMed ID: 6661985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients.
    Pati AK; Parganiha A; Kar A; Soni R; Roy S; Choudhary V
    Chronobiol Int; 2007; 24(6):1179-97. PubMed ID: 18075806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.
    Generali D; Berruti A; Tampellini M; Dovio A; Tedoldi S; Bonardi S; Tucci M; Allevi G; Aguggini S; Milani M; Bottini A; Dogliotti L; Angeli A
    Bone; 2007 Jan; 40(1):182-8. PubMed ID: 16935041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rhythm of serum erythropoietin in myelodysplastic syndromes.
    Pasqualetti P; Collacciani A; Casale R
    Eur Rev Med Pharmacol Sci; 2000; 4(5-6):111-5. PubMed ID: 11710507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal rhythm of serum erythropoietin circulating levels in chronic obstructive pulmonary disease.
    Casale R; Pasqualetti P
    Panminerva Med; 1997 Sep; 39(3):183-5. PubMed ID: 9360419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of myoglobin serum concentrations in healthy subjects demonstrated by cosinor analysis.
    Clerico A; Pilo A; Del Chicca MG; Riente L; Bombardieri S
    Chronobiologia; 1982; 9(1):41-5. PubMed ID: 7140477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
    Moul JW; Connelly RR; Perahia B; McLeod DG
    J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythm of serum erythropoietin in multiple myeloma.
    Pasqualetti P; Collacciani A; Casale R
    Am J Hematol; 1996 Sep; 53(1):40-2. PubMed ID: 8813096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Cancer; 2003 Feb; 97(4):979-83. PubMed ID: 12569596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
    Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
    Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
    Dejter SW; Erickson BA; Lynch JH
    Urology; 1988 Feb; 31(2):125-8. PubMed ID: 3341096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M
    Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J; Lorente JA; Reig C; López Pacios MA; de Torres JA; Soler Roselló A
    Actas Urol Esp; 1994 May; 18(5):559-61. PubMed ID: 7521563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythm of serum erythropoietin in healthy subjects.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1996; 18(3):91-3. PubMed ID: 9177605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.